Magtein wins NI Award for brain health research innovation

'This partnership underscores the transformative potential of our small molecule condensate modulator.'
Magtein neuroscience programme advances understanding of blood-brain barrier and brain magnesium biology (Andrew Brookes/Getty Images/Image Source)

Threotech’s Magtein Brain Magnesium Research Program won NutraIngredients’ Nutrition Research Project Award for combining mechanistic neuroscience with human trials.

The program, which studies how oral magnesium can meaningfully support brain magnesium biology and cognitive function, has so far generated more than 45 peer-reviewed publications since 2010, including five human clinical trials.

Running across three continents and multiple populations, the programme reports improvements in cognition, sleep quality, and physiological resilience markers such as heart rate variability, with further studies planned through 2030.

Dr. Rafea Naffa, Ph.D., director of R&D at Threotech, told NutraIngredients the program “represents a rare example of a fully translational nutrition research pathway sustained over a long period of time”.

“Many supplement research programs begin directly with commercial positioning and then attempt to generate supporting studies afterwards,” Naffa said. “The Magtein research program evolved in the opposite direction.

Explore related questions

Beta

“It began with foundational neuroscience investigating synaptic plasticity, neuronal magnesium regulation, and learning and memory mechanisms long before there was broad commercial interest in brain magnesium.”

Threotech at the NutraIngredients Awards 2026 in Barcelona
Threotech at the NutraIngredients Awards 2026 in Barcelona (alvarog1970/William Reed)

Can magnesium reach the brain?

The original scientific question behind the Magtein research program was very simple: Can oral magnesium meaningfully support brain magnesium biology?

“For decades, magnesium has been recognised as essential for cognitive function, neuronal signalling, stress regulation, synaptic activity, and sleep physiology,” Naffa said. “At the same time, magnesium insufficiency has become a growing global nutritional concern, with estimates suggesting that more than 30% of the global population may not meet recommended daily magnesium intake levels.”

He noted that despite this, one of the major gaps in magnesium nutrition science is that magnesium status is extremely difficult to assess and even more difficult to translate into meaningful brain-related outcomes.

“Most magnesium exists intracellularly or within bone, while blood magnesium is tightly regulated and often poorly reflects functional magnesium status at the tissue level, particularly within the brain,” he said.

Historically, conventional magnesium supplements focused on gastrointestinal absorption and serum blood levels, Naffa said. These largely ignored whether oral magnesium could effectively influence magnesium availability inside neurons, where magnesium plays a central role in synaptic plasticity, neuronal communication, and cognitive processing.

“Foundational neuroscience research demonstrated that the brain tightly regulates magnesium transport across the blood–brain barrier, creating a significant translational gap between oral magnesium intake and functional neurological outcomes,” Naffa said.

“The Magtein research program was established to address this gap by combining mechanistic neuroscience, targeted nutrient delivery, and human clinical validation.”

Magnesium L-threonate research shows benefits for cognition and sleep

As Naffa explained, the program was designed as a long-term research platform rather than a single-study. As technologies and methodologies evolved, the research expanded from foundational neuroscience and synaptic biology into areas including validated composite cognitive assessments, wearable sleep monitoring, autonomic recovery metrics and applications related to healthy aging.

“The goal was not simply to create another magnesium product, but to better understand how magnesium biology can be supported at the neuronal level and whether this can translate into measurable effects on cognition, healthy brain aging, stress resilience and sleep quality,” Naffa said.

The researchers used validated composite cognitive assessments alongside measures of sleep quality, autonomic recovery, real-world performance, and everyday cognitive function to build a more integrated understanding of how nutritional interventions may influence brain health.

The program also helped demonstrate that oral magnesium delivery can meaningfully affect brain magnesium biology and translate into measurable functional outcomes, Naffa noted, and findings have linked magnesium L-threonate to areas such as working memory, processing efficiency, sleep-related recovery, stress resilience and next-day cognitive performance.

“That was not widely accepted when this research program first began,” he said.

Magnesium form and delivery key to brain health

He argued the research contributed to a broader shift in how magnesium is viewed within cognitive nutrition and healthy aging, highlighting the importance of magnesium form and delivery characteristics when targeting brain health.

“Historically, magnesium was largely positioned as a general wellness mineral,” he said. “The Magtein program helped establish the concept that the form and delivery characteristics of magnesium matter.”

He did, however, note that there is still much to learn about how targeted nutritional strategies can support neuronal function and long-term cognitive health.

“We also see growing opportunities to apply newer technologies and methodologies, including advanced cognitive assessment platforms, wearable physiological monitoring, and more personalized approaches to nutrition research,” Naffa said.

He noted that winning the NutraIngredients Award ‘validates the importance of long-term, science-driven innovation within the nutrition industry’.

“The award also reflects growing acceptance that nutrition science can and should be held to higher evidence standards,” Naffa said. “We hope this encourages more translational, mechanism-based research programs across the industry rather than isolated short-term studies designed primarily for marketing purposes.”